- Home
- RIGL vs IBEX Comparison
RIGL vs IBEX Comparison
Compare RIGL & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- IBEX
- Stock Information
- Founded
- RIGL 1996
- IBEX 2017
- Country
- RIGL United States
- IBEX United States
- Employees
- RIGL N/A
- IBEX N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- IBEX EDP Services
- Sector
- RIGL Health Care
- IBEX Technology
- Exchange
- RIGL Nasdaq
- IBEX Nasdaq
- Market Cap
- RIGL 335.5M
- IBEX 337.3M
- IPO Year
- RIGL 2000
- IBEX 2020
- Fundamental
- Price
- RIGL $21.91
- IBEX $27.75
- Analyst Decision
- RIGL Buy
- IBEX Hold
- Analyst Count
- RIGL 5
- IBEX 2
- Target Price
- RIGL $36.40
- IBEX $27.00
- AVG Volume (30 Days)
- RIGL 182.1K
- IBEX 98.6K
- Earning Date
- RIGL 08-05-2025
- IBEX 09-11-2025
- Dividend Yield
- RIGL N/A
- IBEX N/A
- EPS Growth
- RIGL N/A
- IBEX 48.53
- EPS
- RIGL 2.08
- IBEX 2.25
- Revenue
- RIGL $203,077,000.00
- IBEX $535,666,000.00
- Revenue This Year
- RIGL $14.41
- IBEX $9.12
- Revenue Next Year
- RIGL $15.97
- IBEX $5.80
- P/E Ratio
- RIGL $10.11
- IBEX $13.12
- Revenue Growth
- RIGL 70.16
- IBEX 5.35
- 52 Week Low
- RIGL $8.61
- IBEX $15.17
- 52 Week High
- RIGL $29.82
- IBEX $32.08
- Technical
- Relative Strength Index (RSI)
- RIGL 66.30
- IBEX 37.10
- Support Level
- RIGL $19.51
- IBEX $29.44
- Resistance Level
- RIGL $21.41
- IBEX $30.73
- Average True Range (ATR)
- RIGL 0.88
- IBEX 0.81
- MACD
- RIGL 0.24
- IBEX -0.24
- Stochastic Oscillator
- RIGL 96.45
- IBEX 0.28
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About IBEX IBEX Limited
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.